Was ist gesichert in der Therapie des systemischen Lupus erythematodes?article Published on 2023-11-072024-09-02 Journal: Innere Medizin (Heidelberg, Germany) [Category] 대상포진, [키워드] biological therapy Biologika Glucocorticoids Glukokortikoide Hydroxychloroquin Hydroxychloroquine lupus nephritis Lupusnephritis Systemic lupus erythematosus/basic treatment measures Systemischer Lupus erythematodes/Basismaßnahmen [DOI] 10.1007/s00108-023-01624-9 PMC 바로가기 [Article Type] article
[Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm : Perimyocarditis and coagulopathy after administration of tocilizumab][사이토카인 폭풍에서 IL-6 수용체 차단에도 불구하고 코로나19의 치명적인 경과 : 토실리주맙 투여 후 심근주위염 및 응고병증]Case Reports Published on 2021-02-012022-09-11 Journal: Anaesthesist [Category] 진단, 치료제, [키워드] Administered administration Admission ARDS Azithromycin blockade can not Cardiac arrhythmia circulatory shock Clinical deterioration Coagulopathy Course COVID-19 criteria cytokine Cytokine storm diagnosed died ECMO Efficacy English Exacerbation hemodynamic instability hospital Hydroxychloroquin Hydroxychloroquine IL-6 receptor inflammation marker initiated lAbel male moderate multiorgan failure occurred off-label Patient patient selection Perimyocarditis Pneumonia Randomized controlled studies receptor receptor antagonist respiratory insufficiency second dose Shock Tage the patient Tocilizumab Treatment treatment with tocilizumab with COVID-19 worsened [DOI] 10.1007/s00101-020-00871-x PMC 바로가기 [Article Type] Case Reports